June 3, 2019

Phase I testing of our App began June 1 and continues throughout this month.  During this phase, expert clinician reviewers will download, register, and use the Basic Version of the App.  These reviewers will provide feedback through a questionnaire that asks about the functionality, clinical content, and the utility of the App.  Once the International Committee for Congential Anomaly Surveillance Tools gather and analyse all of the feedback, this will inform any further changes to the App before Phase II (field testing) commences.  We sincerely thank the participating reviewers for their time and attention during this critical phase of the App's development.  If you have questions about the App or think you might like to participate in its review, please  contact us.